Science Corporation Raises $400M Series D to Scale PRIMA Retinal Implant
Science Corporation raised a $400M Series D on November 17, 2026, lifting total funding past $900M to expand its CE-marked PRIMA retinal implant in Europe and fund biohybrid neural-interface research.
